Strategic – Optimum Strategic Communications

Novo Holdings participates in $290m strategic financing of Sangon Biotech

17 August 2023/in Client news

Novo Holdings, a leading international life science investor, today announced it has participated in a $290 million (USD) strategic financing round of Sangon Biotech. Sangon is a leading provider of life science tools and services, enabling scientists across China to perform state-of-the-art research in hospitals, universities and commercial settings. Read more…

Optimum Strategic Communications Expands Team to support ongoing growth

30 June 2021/in Insights

Optimum is pleased to announce the appointment of Stella Lempidaki. With a strong scientific background, Stella brings 13 years of experience in life sciences in both academia and startups. Stella was part of the founding team at techspert.io, a Cambridge, UK based technology startup using the power of AI to facilitate knowledge exchange within the […]